The annual rankings from U.S. News are here, with some familiar names making the top of the list. Did your facility make the cut? 

The company has now raised $248M in total to help develop, commercialize and market its FDA-cleared technology. 

Using patient-reported health scores may be able to help guide treatment decisions for patients presenting with coronary artery disease.

Jonathon Leipsic, MD, chairman of the Department of Radiology, University of British Columbia, explains how noninvasive computed tomography angiography (CTA) can be used to aid in planning interventional cardiology procedures for percutaneous coronary intervention (PCI) and chronic total occlusions (CTO). 

Ancora Heart received the FDA’s breakthrough device designation for its AccuCinch Ventricular Restoration System, a new minimally invasive transcatheter device designed for the treatment of heart failure.

“We found direct evidence that the SARS-CoV-2 spike protein is toxic to heart muscle cells," one researcher said. 

More than 15,000 cases have been identified worldwide, according to WHO, with more than two-thirds of cases reported in the WHO European Region.

Point-of-care ultrasound innovator Exo has acquired Medo AI of Edmonton, Alberta, with plans to soon make ultrasound imaging “as easy as snapping a photo on a smartphone.”